 "Here's why Mehul Kothari recommends buying Metropolis, Thyrocare Tech")
BUY
Metropolis
Buy Near: Rs 1,500
Target: Rs 1,800
Stop Loss: Rs 1,350
Like other diagnostic stocks, even Metropolis Healthcare was under corrective mode since many months. In recent sessions, the stock has confirmed a higher top formation on the daily scale.
Also Read
Also, we are witnessing a falling wedge breakout on the daily scale. Thus, we advise traders to buy the stock near Rs 1,500 for a target of Rs 1,800 in the coming sessions.
BUY
Thyrocare
Buy Near: Rs 680
Target: Rs 740
Stop Loss: Rs 650
Even Thyrocare Technologies was under a heavy corrective mode and now has confirmed higher top and higher bottom formation on the daily scale.
At this juncture, the stock has retested its breakout zone and poised for fresh upside. Thus, we advise traders to buy the stock near Rs 680 for a target of Rs 740 in the coming sessions.
(Mehul Kothari - AVP – Technical Research, Anand Rathi Shares & Stock Brokers. Views are personal).
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%